lncRNA, miRNA, and mRNA of plasma and tumor-derived exosomes of cardiac myxoma-related ischaemic stroke

Sci Data. 2025 Jan 16;12(1):91. doi: 10.1038/s41597-025-04410-4.

Abstract

Cardiac myxoma (CM) is an important aetiology of stroke in young adults, and its diagnosis is difficult in patients having stroke because of the lack of diagnostic biomarkers. Tumour-derived exosomes play a crucial role in tumour growth, metastasis, immune regulation, and monitor disease development. Hence,we established an RNA-sequencing dataset for long non-coding RNA (lncRNA), microRNA (miRNA), and messenger RNA (mRNA) in the plasma and tumour-derived exosomes from four patients with cardiac myxoma-related ischaemic stroke (CM-IS) and six patients with cardiac myxoma without ischaemic stroke (non-IS CM). Moreover, 5,533 lncRNAs, 1,331 known miRNAs, and 412 new miRNAs were identified. Finally, gene expression profiles and differentially expressed genes were analysed in 20 samples. In the plasma samples, 74 miRNAs, 12 lncRNAs, and 693 mRNAs were identified, while tumour-derived tissue samples contained 61 miRNAs, 67 lncRNAs, and 433 mRNAs. This dataset provides a significant resource for relevant researchers to explore the potential dysregulated lncRNAs, miRNAs, and mRNAs of plasma and tumour-derived exosomes in CM-IS.

Publication types

  • Dataset

MeSH terms

  • Exosomes* / genetics
  • Heart Neoplasms* / blood
  • Heart Neoplasms* / genetics
  • Humans
  • Ischemic Stroke* / blood
  • Ischemic Stroke* / genetics
  • MicroRNAs* / blood
  • MicroRNAs* / genetics
  • Myxoma* / genetics
  • RNA, Long Noncoding* / blood
  • RNA, Long Noncoding* / genetics
  • RNA, Messenger* / genetics

Substances

  • RNA, Long Noncoding
  • RNA, Messenger
  • MicroRNAs